Log in | Register

Does this patient with thrombotic thrombocytopenic purpura have a cardiac involvement?

Lara Zafrani| Lene Russell| Elie Azoulay
What's New in Intensive Care
Volume 44, Issue 6 / June , 2018

Pages 893 - 896

No abstract available.

References

  1. Mannucci PM (2015) Understanding organ dysfunction in thrombotic thrombocytopenic purpura. Intensive Care Med 41:715–718. https://doi.org/10.1007/s00134-014-3630-z
  2. Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347:589–600. https://doi.org/10.1056/NEJMra020528
    • View reference on publisher's website
    • View reference on PubMed
  3. Joly BS, Coppo P, Veyradier A (2017) Thrombotic thrombocytopenic purpura. Blood 129:2836–2846. https://doi.org/10.1182/blood-2016-10-709857
    • View reference on publisher's website
    • View reference on PubMed
  4. Peigne V, Perez P, Resche Rigon M et al (2012) Causes and risk factors of death in patients with thrombotic microangiopathies. Intensive Care Med 38:1810–1817. https://doi.org/10.1007/s00134-012-2638-5
  5. Brain MC (1978) An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries (Moschcowitz 1925). Thromb Haemost 40:9–10
    • View reference on PubMed
  6. Benhamou Y, Boelle P-Y, Baudin B et al (2015) Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center. J Thromb Haemost JTH 13:293–302. https://doi.org/10.1111/jth.12790
    • View reference on publisher's website
    • View reference on PubMed
  7. Mariotte E, Blet A, Galicier L et al (2013) Unresponsive thrombotic thrombocytopenic purpura in critically ill adults. Intensive Care Med 39:1272–1281. https://doi.org/10.1007/s00134-013-2873-4
  8. Hosler GA, Cusumano AM, Hutchins GM (2003) Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases. Arch Pathol Lab Med 127:834–839. https://doi.org/10.1043/1543-2165(2003)127%3C834:TTPAHU%3E2.0.CO;2
    • View reference on PubMed
  9. Ridolfi RL, Hutchins GM, Bell WR (1979) The heart and cardiac conduction system in thrombotic thrombocytopenic purpura. A clinicopathologic study of 17 autopsied patients. Ann Intern Med 91:357–363
    • View reference on publisher's website
    • View reference on PubMed
  10. Tasaki T, Yamada S, Nabeshima A et al (2015) An autopsy case of myocardial infarction due to idiopathic thrombotic thrombocytopenic purpura. Diagn Pathol 10:52. https://doi.org/10.1186/s13000-015-0285-1
    • View reference on publisher's website
    • View reference on PubMed
  11. Balasubramaniyam N, Kolte D, Palaniswamy C et al (2013) Predictors of in-hospital mortality and acute myocardial infarction in thrombotic thrombocytopenic purpura. Am J Med 126(1016):e1–e7. https://doi.org/10.1016/j.amjmed.2013.03.021
  12. Hawkins BM, Abu-Fadel M, Vesely SK, George JN (2008) Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion (Paris) 48:382–392. https://doi.org/10.1111/j.1537-2995.2007.01534.x
  13. Hughes AK, Stricklett PK, Padilla E, Kohan DE (1996) Effect of reactive oxygen species on endothelin-1 production by human mesangial cells. Kidney Int 49:181–189
    • View reference on publisher's website
    • View reference on PubMed
  14. Morici N, Cantoni S, Panzeri F et al (2017) von Willebrand factor and its cleaving protease ADAMTS13 balance in coronary artery vessels: lessons learned from thrombotic thrombocytopenic purpura. A narrative review. Thromb Res 155:78–85. https://doi.org/10.1016/j.thromres.2017.05.011
    • View reference on publisher's website
    • View reference on PubMed
  15. Georgiades F, Demosthenous S, Braimi M et al (2015) Takotsubo cardiomyopathy and thrombotic thrombocytopenic purpura preceding a lupus diagnosis: a case report. Lupus 24:1443–1447. https://doi.org/10.1177/0961203315593165
    • View reference on publisher's website
    • View reference on PubMed
  16. Scully M, Hunt BJ, Benjamin S et al (2012) Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 158:323–335. https://doi.org/10.1111/j.1365-2141.2012.09167.x
    • View reference on publisher's website
    • View reference on PubMed
  17. Peyvandi F, Scully M, Kremer Hovinga JA et al (2016) Caplacizumab for acquired thrombotic thrombocytopenic purpura. N Engl J Med 374:511–522. https://doi.org/10.1056/NEJMoa1505533
    • View reference on publisher's website
    • View reference on PubMed
  18. Gami AS, Hayman SR, Grande JP, Garovic VD (2005) Incidence and prognosis of acute heart failure in the thrombotic microangiopathies. Am J Med 118:544–547. https://doi.org/10.1016/j.amjmed.2005.02.019
    • View reference on publisher's website
    • View reference on PubMed
  19. Maino A, Siegerink B, Lotta LA, Crawley JT, le Cessie S, Leebeek FW, Lane DA, Lowe GD, Peyvandi F, Rosendaal FR (2015) Plasma ADAMTS-13 levels and the risk of myocardial infarction: an individual patient data meta-analysis. J Thromb Haemost 13(8):1396–1404
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement